Introduction Biological and precision therapies are increasingly used in cancer treatment.
Although they may improve survival, they are also associated with various—and unique …

Introduction Biological and precision therapies are increasingly used in cancer treatment.
Although they may improve survival, they are also associated with various—and unique …

Purpose: The current clinical trials development and conduct process is cumbersome and
expensive, with the majority of studies focusing on either the development of new agents or …

Precision oncology has made remarkable strides in improving clinical outcomes, offering
hope to patients with historically difficult-to-treat, as well as rare or neglected cancers …

Background Biological and precision therapies have the potential to transform prognosis of
patients diagnosed with advanced cancer. Their availability has exploded in recent years …

Background Biological and precision therapies (known as targeted therapies) have been a
significant success in the treatment of metastatic cancer. The number licenced is continually …

While we as clinicians strive to obtain best possible outcomes for our patients, there is a risk
that adhering to a system that has brought significant breakthroughs in cancer may not be …

Purpose The support needs of cancer patients vary according to the phase of their cancer
journey. Recent developments in healthcare are such that the advanced cancer phase is …

In this 21st century, we will need to better analyse the outcomes of our spending on newer
and more expensive anticancer drugs, particularly through postmarketing assessment, to …

The Bloomberg New Economy International Cancer Coalition brings together academia,
industry, government, patient advocacy and policy think tanks to leverage technology and …